By Nathan Vardi and Matthew HerperWe knew Gary Cohn, the former Goldman Sachs executive President Donald Trump picked to be a top economic advisor, is rich. No surprise, then, that Trump Administration financial disclosures released last night show he has assets worth between $252 million and $611 million. But here’s a surprise: Cohn disclosed he owns shares in a little known biotechnology company that is developing drugs to reverse symptoms of aging, aiming to reverse conditions like baldness and arthritis. According to the financial disclosure form, Cohn has made two investments in Samumed LLC, described as a medical technology company in California. Both Cohn’s investments in Samumed are valued at more than $1 million each.

Source: Forbes April 01, 2017 15:10 UTC